WILLEM OVERWIJK to Prostatic Neoplasms
This is a "connection" page, showing publications WILLEM OVERWIJK has written about Prostatic Neoplasms.
Connection Strength
0.019
-
Antigen-specific tumor vaccine efficacy in vivo against prostate cancer with low class I MHC requires competent class II MHC. Prostate. 2002 Nov 01; 53(3):183-91.
Score: 0.016
-
An autologous oral DNA vaccine protects against murine melanoma. Proc Natl Acad Sci U S A. 2000 May 09; 97(10):5492-7.
Score: 0.003